StreetAlpha.app
Home › Stocks › KOD

Kodiak Sciences Inc. (KOD)

Healthcare
$96.80
▼ −3.90%
LAST CLOSE · NOV 17

Kodiak Sciences develops drug treatments for retinal eye diseases, with its lead candidate still in clinical trials. It last closed at $96.80 on Nov 17, down 3.90% on the day. The average 12-month price target from 4 analysts is $114.25 (+18.0% from the last close), with a high of $150.00 and a low of $36.00. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (3 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 7 whale options trades in KOD, 71% of them bullish and 29% bearish. In the past 30 days there were 1 dark pool print totaling $1.0M, the largest $1.0M.

AI Auto Pilots
Is KOD in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Net income
−$246.8M
EPS (diluted)
−$4.08
Free cash flow
−$172.8M
Valuation
Market cap
$6.3B
65.4M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$88.7M
At Sep 30
Shareholder equity
$12.6M
Shares outstanding
65.4M
At Nov 9
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −$267.0M−$267.0MFY2021FY2022: −$333.8M−$333.8MFY2022FY2023: −$260.5M−$260.5MFY2023FY2024: −$176.2M−$176.2MFY2024FY2025: −$230.0M−$230.0MFY2025

From KOD's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 12). Last 12 months adds up the four latest quarters.

Last report
Nov 12
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Strong Buy
Based on 4 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
4firms
3 Buy1 Hold0 Sell
Each firm's latest rating on KOD in the past 90 days
Average 12-month target
$114.25
▲ 18.0% upside

Based on 4 analysts who set a price target on KOD in the past 90 days. The average target is $114.25, with a high of $150.00 and a low of $36.00, compared with the last close of $96.80.

$22$68$114$159PAST 15 TRADING DAYS12-MONTH TARGETSHIGH $150AVG $114.25LOW $36Jul 10LAST CLOSE+12 MO$22$68$114$159PAST 15 DAYSTARGETSHIGH $150AVG $114.25LOW $36Jul 10LAST CLOSE+12 MO
Highest target$150.00
Average target$114.25
Lowest target$36.00
Latest rating changes
UBSTarget raised
Nov 13Buy$120 → $150
HC Wainwright & Co.Target raised
Oct 12Buy$96 → $126
LifeSci CapitalMaintained
Sep 28Buy$145
UBSMaintained
Sep 28Buy$120
HC Wainwright & Co.Target raised
Sep 28Buy$58 → $96
DateFirmActionRatingPrice target
Nov 13UBSTarget raisedBuy$120 → $150
Oct 12HC Wainwright & Co.Target raisedBuy$96 → $126
Sep 28LifeSci CapitalMaintainedBuy$145
Sep 28UBSMaintainedBuy$120
Sep 28HC Wainwright & Co.Target raisedBuy$58 → $96
Loading…

Technical Analysis

KOD · as of the Nov 17 close · updated after every close
Uptrend

The stock sits between its 20 and 50 day averages. It is 52% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 52). The nearest support is the Pivot S1 at $92.84, and the nearest resistance the 20 day average at $98.27.

Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 7.3%/day
Key levels
$112.6852 week high+16.4%
$103.27Swing high (Oct 12)+6.7%
$102.56Pivot R1+6.0%
$98.60Pivot+1.9%
$98.2720 day average+1.5%
$96.80Last close
$92.84Pivot S1−4.1%
$90.50Swing low (Nov 5)−6.5%
$79.2650 day average−18.1%
$59.76100 day average−38.3%
$46.68200 day average−51.8%
$18.1552 week low−81.3%
Indicators
RSI (14)51.87Middle of its rangeNeutral
MACD6.33Below its signal lineBearish
Stochastic56.5Middle of its rangeNeutral
ADX (14)30.9Trending up
Williams %R-71.6Oversold below −80, overbought above −20Neutral
CCI (20)3.3Oversold below −100, overbought above 100Neutral
Rate of change−2.1%Change over 10 sessionsBearish
ATR (14)$7.07Typical daily range, 7.3% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for KOD

What happened before

See how KOD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bullish5 bullish and 2 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow KOD usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How KOD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
7
Bullish
5
71%
Bearish
2
29%
Date span
Sep 16 – Oct 27
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
1
Notional
$1.0M
Largest print
$1.0M
Loading…

KOD Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●110 buying vs 113 selling
  • ●Held by funds -0.2 pts
  • ▲Funds holding +17
  • ●Superinvestors: 2 added, 2 cut
  • ▼Put/call 0.33 to 0.70
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding217200+8.5%
In funds' top 10107+42.9%
Held by funds92.3%92.5%−0.2 pts
New / increased51 / 5935 / 81−5.2%
Reduced / sold out79 / 3455 / 24+43.0%
Put/call ratio0.700.33+107.9%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See KOD institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether KOD is in one of them and how their past KOD trades turned out.

KOD in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered KOD in an article yet. Here's the latest on the wider market.

KOD Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Dec 12
Who traded KOD · since 2022
Latest 2 filings
$1K – $15KTraded Nov 8, 2022Filed Dec 12, 2022
$1K – $15KTraded Jul 18, 2022Filed Sep 9, 2022
PersonTypeAmountTradedFiledDelay
Christopher JacobsR · NYSell$1K – $15KNov 8, 2022Dec 12, 202234 d
Christopher JacobsR · NYBuy$1K – $15KJul 18, 2022Sep 9, 202253 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Kodiak Sciences

Kodiak Sciences is a biotechnology company based in Palo Alto, California, that develops drugs for diseases of the retina, the light sensitive tissue at the back of the eye. Its candidates are built on its Antibody Biopolymer Conjugate platform, which is designed to keep drugs active in the eye for longer. The lead candidate, tarcocimab, is in Phase 3 trials for conditions such as wet macular degeneration and diabetic retinopathy and has not yet been approved for sale.

Headquarters
Palo Alto, CA